| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |